MonicaMarieBertagnolliMD
General Surgery • Boston, MASurgical Oncology (Other than Breast)
Chief, Division of Surgical Oncology, Brigham and Women's Hospital Professor of Surgery, Harvard Medical School
Dr. Bertagnolli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis St
Boston, MA
Boston, MA 02115Phone+1 617-732-8910Fax+1 617-582-6177- Is this information wrong?
Education & Training
Brigham and Women's HospitalResidency, Surgery, 1985 - 1989
University of Utah School of MedicineClass of 1985
Certifications & Licensure
MA State Medical License 1987 - 2025
WY State Medical License 2021 - 2024
NY State Medical License 1994 - 2001- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2010-2013
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Gene Testing in Patients With Colon Cancer Start of enrollment: 1998 Aug 01
- Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps Start of enrollment: 2000 Mar 01
- Genetic Study of Familial Factors in Patients With Colon Cancer Start of enrollment: 2001 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsThe Influence of Social Determinants on Receiving Outpatient Treatment with Monoclonal Antibodies, Disease Risk, and Effectiveness for COVID-19.O'Horo, J. C., Nalini Ambrose, Alpesh Amin, Brian Anderson, Monica Bertagnolli, Francis Campion, Dan Chow, Risa Danan, Lauren D'Arinzo, Ashley Drews, Karl Erlandson, K...> ;Journal of General Internal Medicine. 2023 Dec 1
- 4 citationsNeutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes.Nalini Ambrose, Alpesh Amin, Brian Anderson, Julio Barrera-Oro, Monica Bertagnolli, Francis Campion, Daniel Chow, Risa Danan, Lauren D'Arinzo, Ashley Drews, Karl Erlan...> ;JAMA Network Open. 2023 Apr 3
- 4 citationsConcurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST.Inga-Marie Schaefer, Matthew L Hemming, Meijun Z Lundberg, Matthew P Serrata, Isabel Goldaracena, Ninning Liu, Peng Yin, Joao A Paulo, Steven P Gygi, Suzanne George, J...> ;British Journal of Cancer. 2022 Nov 1
- Join now to see all
Press Mentions
AACR Annual Meeting 2023: Closing Plenary Highlights Research Breakthroughs and Next StepsMay 22nd, 2023- Biden’s Pick to Lead the NIH Faces an Uphill BattleMay 18th, 2023
- Oncology Clinician, Researcher, Advocate—and Patient Herself—to Become Second Woman to Lead NIHMay 16th, 2023
- Join now to see all
Grant Support
- Acosog Competing RenewalNational Cancer Institute2012
- Cancer And Leukemia Group BNational Cancer Institute2009–2012
- Characterizing Disease And Treatment Response In Colon Cancer ChemopreventionNational Cancer Institute2008–2012
- Advanced Training In Surgical OncologyNational Cancer Institute2011
- Cancer And Leukemia Group B Human Specimen RepositoriesNational Cancer Institute2010–2011
- Cancer And Leukemia Group B CCOP Research BaseNational Cancer Institute2010–2011
- Phase II Clinical Trial Of Celecoxib (Or Nsaid) For Prevention Of Sporadic ColorNational Cancer Institute2007
- Epithelial Homeostasis In APC Gene MutationNational Cancer Institute2000–2001
- Phase II Clinical Trial Of Celecoxib (Or Nsaid)Division Of Cancer Prevention And Control1999–2000
- Epithelial Homeostasis In APC Gene MutationNational Cancer Institute1997–1999
Professional Memberships
- Member
- Member
Hospital Affiliations
Brigham and Women's HospitalBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Salem HospitalSalem, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
